2023 International Congress » Epidemiology

Meeting: 2023 International Congress

A 20-year review of a Movement Disorders Database in Singapore

YH. Nah, S. Neo, S. Ng, N. Chia, HL. Ng, W. Li, A. Zhan, KY. Tay, Z. Xu, WL. Au, L. Tan (Singapore, Singapore)

Applying the COM-B model to identify potential barriers for in-person on-site visits within the Healthy Brain Ageing (HeBA) study in Luxembourg

L. Vilas Boas, O. Tsurkalenko, T. Marques, E. Thiry, AM. Hanff, R. Krüger, C. Horlings, A. Garrido, C. Vega, S. Schade, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, C. Pauly, D. Mcintyre, K. Seppi, M. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, B. Mollenhauer (Strassen, Luxembourg)

Association Between Antiepileptic Drugs and Subsequent Parkinson’s Disease in East London

Q. Zhang, J. Bestwick, R. Dobson, C. Marshall, A. Noyce (London, United Kingdom)

Characterizing Hospital Admissions in Parkinson’s Disease: 10-Year Retrospective Study of Administrative Data in Alberta, Canada

Y. Mahjoub, V. Bruno, S. Peters (Calgary, Canada)

Drivers of longitudinal healthcare cost in Parkinson Disease

S. Neo, SW. Goh, ES. Saffari, AB. Zhan, HL. Ng, W. Li, R. Hoe, Z. Xu, KY. Tay, WL. Au, LCS. Tan (Singapore, Singapore)

Dry Cleaning Chemicals and Parkinson’s Disease

M. Pawlik, S. Lettenberger, M. Zafar, P. Auinger, K. Hylton, M. Coffey, S. Goldman, B. de Miranda, K. Kieburtz, H. Schwarz, R. Barbano, M. Braun, J. Adams, D. Kinel, R. Dorsey (Rochester, USA)

Epidemiology of late-onset Parkinson’s disease in least-developed to Upper Middle-Income Countries: A Systematic Review and Meta-analysis

G. Pereira, N. Soares, D. Teixeira-Dos-Santos, G. Marconi, D. Friedrich, C. Rieder, A. Schumacher-Schuh (Porto Alegre, Brazil)

Estimating the Incidence of Parkinson’s Disease in Patients with Epilepsy: A Nationwide Cohort Study in South Korea

YS. Hwang, MG. Kang, MG. Lee, SW. Yeom, BS. Shin, JS. Kim, HG. Kang (Jeonju-si, Jeonbuk-do, Republic of Korea)

Estimation of global age-specific prevalence of essential tremor by literature review of population-based studies

J. Furtado, C. Lally, WD. Flanders, M. Gerbasi, N. Maserejian (Cambridge, USA)

Filipino’s and Parkinson’s Disease: A Scoping Review of the Literature

E. Krening, T. Seto, M. Bruno (Honolulu, USA)

Frequency of Parkinson disease following COVID-19 infection: a two-year retrospective cohort study

A. Wang, J. Perez, S. Gunzler (Cleveland, USA)

Frequency of Parkinson’s Disease in All Case Hospitalization Among Native Hawaiian/Pacific Islanders, Asian American Subgroups and Whites

M. Bruno, M. Matsunaga, E. Krening, J. Chen, G. Ross (Honolulu, USA)

Impact of the COVID-19 pandemic on DBS accessibility: a single center experience

F. Sarmento, S. Aghili-Mehrizi, T. de Araujo, J. Wong (Gainesville, USA)

Movement disorders at the National Institute of Neurology and Neurosurgery (INNN, Mexico City): most common diagnoses during 2022.

D P. Romero Teran, A J. Hernández Medrano, D R. Aguila Godinez, A A. Herrera Ruiz, E C. Santiago Cruz, M. Medrano Delgado, M A. Ruiz Mafud, A Y. Regalado Mustafá, M F. Medina Perez, G I. Cerda Hernández, M. Rodriguez Violante, A. Cervantes Arriaga, G. Hernandez Armesto, A. Abundes Corona, A. Dominguez Garcia, K. Talavera Lagunas (CDMX, Mexico)

National Luxembourg Sleep Study: An enriched, at risk, prodromal Parkinson’s Disease cohort

D. Mcintyre, L. Pavelka, C. Pauly, G. van Cutsem, O. Tsurkalenko, T. Marques, C. Gomes, S. Jonsdottir, J. Welch, K. Gunter, G. Aguayo, A. Sharify, E. Rosalès-Jubal, M. Vaillant, V. Satagopam, S. Ghosh, C. Vega Moreno, K. Roomp, A. Pincherle, M. Gantenbein, N. Diederich, M. Hu, R. Krüger, L. Vilas Boas (Luxembourg, Luxembourg)

Nutritional traits in the prodromal phase on Parkinson’s disease in community-dwelling older adults in Japan

T. Yamaguchi, R. Nozaki, K. Taguchi, Y. Suzuki, K. Takahashi, K. Takahashi, K. Iwaoka, Y. Sato, T. Terauchi, H. Akasaka, N. Ishizuka, T. Maeda (Iwate, Japan)

Obesity is a protective factor for the development of Parkinson’s disease in participants of the Framingham Heart Study Cohort

S. O'Shea, Y. Liu, C. Liu, S. Frank, R. Au (New York, USA)

Prevalence and clinical characteristics of young onset Parkinson’s Disease among Nepalese Population

R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari (Kathmandu, Nepal)

Prevalence of depression and cognitive impairment in a Hungarian Parkinson’s disease Center

EK. Balogh, E. Balogh, A. Mező, M. Bokor (Budapest, Hungary)

Prevalence, clinical characteristics, and quality of life of orthostatic tremor and orthostatic myoclonus in Thai patients with Parkinson’s disease: Prospective cross-sectional study

P. Kiatsermsakul, Y. Pitakpatapee, W. Saengphatarachai, K. Boonyapisit, P. Srivanitchapoom (Bangkok, Thailand)

Publication rates and characteristics of clinical trials in deep brain and responsive neurostimulation

M. Chua, A. Warren, J. Rolston (Boston, USA)

Risk and protective factors in Parkinson’s disease: a simultaneous and prospective study with linear and machine learning models

MI. de Bartolo, A. Gialluisi, S. Costanzo, D. Belvisi, S. Falciglia, M. Ricci, A. Di Castelnuovo, T. Panzera, MB. Donati, G. Fabbrini, G. de Gaetano, A. Berardelli, L. Iacoviello (Pozzilli, Italy)

The comparison of vaccination rate, health impact, and confidence of COVID-19 vaccines between patients with Parkinson’s disease and healthy population: evidence from a large multicenter survey in China

C. Han, Z. Zhao, J. Ma (Beijing, China)